Literature DB >> 12905030

A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.

Kamilla Angelo1, Yuliya V Korolkova, Morten Grunnet, Eugene V Grishin, Kirill A Pluzhnikov, Dan A Klaerke, Hans-Günther Knaus, Morten Møller, Søren-Peter Olesen.   

Abstract

The wild-type scorpion toxin BeKm-1, which selectively blocks human ether-a-go-go related (hERG) channels, was radiolabeled with iodine at tyrosine 11. Both the mono- and di-iodinated derivatives were found to be biologically active. In electrophysiological patch-clamp recordings mono-[127I]-BeKm-1 had a concentration of half-maximal inhibition (IC50 value) of 27 nM, while wild-type BeKm-1 inhibited hERG channels with an IC50 value of 7 nM. Mono-[125I]-BeKm-1 was found to bind in a concentration-dependent manner and with picomolar affinity to hERG channel protein in purified membrane vesicles from transfected human embryonic kidney cells (HEK-293). Under optimized conditions the equilibrium dissociation constant ( Kd) values from saturation and kinetic binding analysis were 13 and 14 pM, respectively. Both the association and dissociation of [(125)I]-BeKm-1 were fast (association rate constant, k(on)=3.6 x 10(7) M(-1)s(-1); dissociation rate constant, k(off)=0.005 s(-1)). Wild-type BeKm-1 displaced binding of [125I]-BeKm-1 with half-maximal inhibitory concentrations of 44 pM. In contrast, competition experiments with a BeKm-1 mutant BeKm-1-K18A, in which the toxin interaction site is disrupted, resulted in a drop in affinity by more than 300-fold as compared to the wild-type toxin. Iberiotoxin and apamin, peptide inhibitors of Ca2+-activated K+-channels, had no effect on [125I]-BeKm-1 binding. Adding the classical rapid delayed rectifier current (IKr) blocker E-4031 reduced binding of [125I]-BeKm-1 to the hERG channel to an IC50 of 7 nM. In autoradiographic studies on rat hearts, binding of [125I]-BeKm-1 was dose-dependent and could partially be displaced by the addition of excess amounts of non-radioactive BeKm-1. The density of the radioactive signal was equally distributed in the myocardium of both the ventricle and atria indicating a homogenous expression of hERG channels throughout the heart.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12905030     DOI: 10.1007/s00424-003-1125-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  25 in total

1.  Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell.

Authors:  A A Selyanko; J K Hadley; I C Wood; F C Abogadie; P Delmas; N J Buckley; B London; D A Brown
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

2.  Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development.

Authors:  D Franco; S Demolombe; S Kupershmidt; R Dumaine; J N Dominguez; D Roden; C Antzelevitch; D Escande; A F Moorman
Journal:  Cardiovasc Res       Date:  2001-10       Impact factor: 10.787

3.  [125I]Iberiotoxin-D19Y/Y36F, the first selective, high specific activity radioligand for high-conductance calcium-activated potassium channels.

Authors:  A Koschak; R O Koch; J Liu; G J Kaczorowski; P H Reinhart; M L Garcia; H G Knaus
Journal:  Biochemistry       Date:  1997-02-18       Impact factor: 3.162

4.  Separation of M-like current and ERG current in NG108-15 cells.

Authors:  H Meves; J R Schwarz; I Wulfsen
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.

Authors:  L M Helms; J P Felix; R M Bugianesi; M L Garcia; S Stevens; R J Leonard; H G Knaus; R Koch; S G Wanner; G J Kaczorowski; R S Slaughter
Journal:  Biochemistry       Date:  1997-03-25       Impact factor: 3.162

6.  M-type K+ current inhibition by a toxin fron the scorpion Buthus eupeus.

Authors:  A K Filippov; S A Kozlov; K A Pluzhnikov; E V Grishin; D A Brown
Journal:  FEBS Lett       Date:  1996-04-22       Impact factor: 4.124

Review 7.  Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Andrea Cavalli; Maurizio Recanatini; Nicola Montanaro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  [125I]margatoxin, an extraordinarily high affinity ligand for voltage-gated potassium channels in mammalian brain.

Authors:  H G Knaus; R O Koch; A Eberhart; G J Kaczorowski; M L Garcia; R S Slaughter
Journal:  Biochemistry       Date:  1995-10-17       Impact factor: 3.162

9.  Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action.

Authors:  M C Sanguinetti; N K Jurkiewicz; A Scott; P K Siegl
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

10.  A toxin to nervous, cardiac, and endocrine ERG K+ channels isolated from Centruroides noxius scorpion venom.

Authors:  G B Gurrola; B Rosati; M Rocchetti; G Pimienta; A Zaza; A Arcangeli; M Olivotto; L D Possani; E Wanke
Journal:  FASEB J       Date:  1999-05       Impact factor: 5.191

View more
  4 in total

Review 1.  Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective.

Authors:  C E Pollard; J-P Valentin; T G Hammond
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

2.  Fluorescent analogues of BeKm-1 with high and specific activity against the hERG channel.

Authors:  Lucie Vasseur; Alain Chavanieu; Stéphanie Combemale; Cécile Caumes; Rémy Béroud; Michel De Waard; Pierre Ducrot; Jean A Boutin; Gilles Ferry; Thierry Cens
Journal:  Toxicon X       Date:  2019-02-23

Review 3.  Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering.

Authors:  Zachary L Bergeron; Jon-Paul Bingham
Journal:  Toxins (Basel)       Date:  2012-11-01       Impact factor: 4.546

4.  Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.

Authors:  Stephan De Waard; Jérôme Montnach; Barbara Ribeiro; Sébastien Nicolas; Virginie Forest; Flavien Charpentier; Matteo Elia Mangoni; Nathalie Gaborit; Michel Ronjat; Gildas Loussouarn; Patricia Lemarchand; Michel De Waard
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.